New Urethral Reconstruction in Robot-assisted Laparoscopic Radical Resection

Launched by QILU HOSPITAL OF SHANDONG UNIVERSITY · Apr 6, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to help men with prostate cancer who are having surgery to remove their prostate. The study aims to compare a new method of reconstructing the urethra (the tube that carries urine out of the body) with a standard technique called anastomosis. The main goal is to see if the new method helps patients regain better control over their urination after surgery, especially for those who experience urinary incontinence, which is when they have trouble controlling their bladder.

To participate in this trial, men must be at least 18 years old and have been diagnosed with prostate cancer that can be treated with surgery. They should not have severe heart or brain issues, or other serious health problems that could complicate the surgery. If eligible, participants will either receive the new reconstruction method or the standard technique during their robot-assisted surgery. This trial is currently recruiting participants, and it could provide valuable insights into improving recovery and quality of life for men undergoing prostate cancer treatment.

Gender

MALE

Eligibility criteria

• Inclusion criteria:
• • Age ≥ 18 years old, confirmed by puncture pathology as prostate cancer
• • The tumor has no extensive distant metastasis, or has reached a resectable state through neoadjuvant chemotherapy and endocrine therapy
• • Willing to accept robot assisted laparoscopic radical prostatectomy
• Exclusion criteria:
• • Tumor metastasis cannot achieve curative effect through surgery
• • Concomitant severe cardiovascular and cerebrovascular complications
• • Merge severe mental and neurological disorders
• • Poor liver and kidney function
• • Refusal to accept robot assisted laparoscopic radical prostatectomy